Author

D S Cohen

Observed name: Deirdre J. Cohen

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Observed institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

OpenAlex ID: A5110104185

Effect of multiple standardized patients on case and examination means and passing rates

1999 · M H Swartz, J A Colliver, et al. · Academic Medicine · 7

Health-related quality of life (HRQOL) in the phase 3 trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502, ATOMIC).

2026 · Amylou C. Dueck, Briant Fruth, et al. · Journal of Clinical Oncology · 1

Chemoimmunotherapy with or without locoregional therapy for biliary tract cancer: A propensity score–matched study.

2026 · Soravis Alm Osataphan, Rodrigo Paredes, et al. · Journal of Clinical Oncology

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: Outcomes from the microsatellite instability-high population of the phase 3 KEYNOTE-585 study.

2026 · Sun Young Rha, Lucjan Wyrwicz, et al. · Journal of Clinical Oncology

BXQ-350 in combination with FOLFOX7 and bevacizumab: Evaluation of effect on oxaliplatin-induced CIPN and neutropenia—A phase 1b/2a trial to assess the efficacy and safety of BXQ-350, a first-in-class sphingolipid metabolism modulator, in newly diagnosed metastatic colorectal carcinoma.

2026 · Tariq Arshad, Michael Gazda, et al. · Journal of Clinical Oncology

Works count: 5

Citation count: 8

H-index: 1

I10-index: